<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01406678</url>
  </required_header>
  <id_info>
    <org_study_id>WDHZ-TC-0801</org_study_id>
    <nct_id>NCT01406678</nct_id>
  </id_info>
  <brief_title>Remote Ischemic Preconditioning in Coronary Artery Bypass Grafting With Cold Crystalloid Cardioplegic Arrest</brief_title>
  <official_title>Effect of Remote Ischemic Preconditioning in Patients Undergoing On-pump Coronary Artery Bypass Graft Surgery With Crystalloid Cardioplegic Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Essen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Remote ischemic preconditioning (RIPC) with transient upper limb ischemia/reperfusion reduces
      myocardial injury in patients undergoing on-pump coronary artery bypass (CABG) surgery with
      cross-clamp fibrillation or blood cardioplegia for myocardial protection. The present study
      assesses protection of heart, brain and kidney by RIPC under crystalloid cardioplegic arrest.
      The study also addresses safety and clinical outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Remote ischemic preconditioning (RIPC) protocol after induction of anesthesia and before skin
      incision consists of 3 cycles of 5 minutes left upper arm ischemia by inflation of a blood
      pressure cuff to 200 mmHg and 5 minutes of reperfusion. For myocardial molecular analyses,
      left ventricular biopsies are taken before induction of cardioplegic cardiac arrest and at 10
      minutes after aortic unclamping during reperfusion of the myocardium.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perioperative extent of myocardial injury as measured by cardiac troponin I serum release over 72 hours after CABG surgery and its area under the curve (AUC).</measure>
    <time_frame>72 hours postoperatively after CABG surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>30 days and 1 year and complete follow-up after CABG surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac and cerebrovascular events (MACCE)</measure>
    <time_frame>at 30 days and 1 year and complete follow-up after CABG surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>30 days and 1 year and complete follow-up after CABG surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal function</measure>
    <time_frame>72 hours post CABG</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Myocardial Injury</condition>
  <arm_group>
    <arm_group_label>RIPC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Remote ischemic preconditioning (RIPC) protocol before coronary artery bypass surgery consists of 3 cycles of 5 minutes left upper arm ischemia by inflation of a blood pressure cuff to 200 mmHg and 5 minutes of reperfusion after induction of anesthesia before coronary artery bypass surgery. For myocardial molecular analyses, left ventricular biopsies are taken before induction of cardioplegic cardiac arrest and 5 and 10 Minutes after aortic unclamping during reperfusion of the myocardium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group: Coronary artery bypass surgery without remote ischemic preconditioning protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>RIPC</intervention_name>
    <description>3 cycles of 5 min left upper arm ischemia by inflation of a blood pressure cuff to 200 mmHg and 5 min reperfusion</description>
    <arm_group_label>RIPC</arm_group_label>
    <other_name>RIPC: Remote ischemic preconditioning</other_name>
    <other_name>CABG: Coronary artery bypass grafting</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Coronary artery bypass surgery without remote ischemic preconditioning protocol</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Coronary artery bypass surgery</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>isoflurane+sufentanil anesthesia</intervention_name>
    <description>Anaesthesia is maintained by inhaled isoflurane in concentrations 0.7-0.8 % end-tidal with additional sufentanil injected during surgery, as required. During extracorporal circulation patients receive isoflurane via a vaporizer incorporated in the extracorporeal gas supply in the same concentrations.</description>
    <arm_group_label>RIPC</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <other_name>Isoflurane, (2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane), Forane</other_name>
    <other_name>Sufentanil, Sufenta, (R-30730)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients &gt;18 years of age

          -  Double- or triple-vessel coronary artery disease

          -  Elective isolated first-time CABG

          -  Combined valve surgery + CABG

          -  Written informed consent

        Exclusion Criteria:

          -  Renal failure (creatinine ≥ 200 µmol/L)

          -  Peripheral vascular disease affecting upper limbs

          -  Preoperative inotropic support

          -  Any kind of mechanical assist device

          -  Acute or recent (&lt;4 weeks) acute coronary syndromes

          -  Any PCI (&lt;6 weeks)

          -  Any reasons for preoperative cTnI elevation

          -  Emergency surgery

          -  Redo surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthias Thielmann, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Thoracic and Cardiovascular Surgery, West-German Heart Center, University Duisburg-Essen, Essen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eva Kottenberg, M.D., PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik für Anästhesiologie und Intensivmedizin, Universität Duisburg-Essen, Universitätsklinikum Essen, Essen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gerd Heusch, M.D., PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut für Pathophysiologie, Universität Duisburg-Essen, Universitätsklinikum Essen, Essen, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matthias Thielmann, MD, PhD</last_name>
    <phone>+49-723-84908</phone>
    <email>matthias.thielmann@uni-due.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Thoracic and Cardiovascular Surgery, West-German Heart Center, University Duisburg-Essen</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Thielmann, MD, PhD</last_name>
      <phone>+49-201-723-84908</phone>
      <email>matthias.thielmann@uni-due.de</email>
    </contact>
    <investigator>
      <last_name>Matthias Thielmann, MD., PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Thielmann M, Kottenberg E, Boengler K, Raffelsieper C, Neuhaeuser M, Peters J, Jakob H, Heusch G. Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Res Cardiol. 2010 Sep;105(5):657-64. doi: 10.1007/s00395-010-0104-5. Epub 2010 May 21.</citation>
    <PMID>20495811</PMID>
  </results_reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2009</study_first_submitted>
  <study_first_submitted_qc>July 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2011</study_first_posted>
  <last_update_submitted>May 11, 2016</last_update_submitted>
  <last_update_submitted_qc>May 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Essen</investigator_affiliation>
    <investigator_full_name>Matthias Thielmann</investigator_full_name>
    <investigator_title>Matthias Thielman, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>remote ischemic preconditioning</keyword>
  <keyword>coronary artery bypass grafting</keyword>
  <keyword>myocardial injury</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

